MAPT and early-onset autosomal dominant Alzheimer disease: The association between HF and dementia has to be proven in longitudinal studies involving also specific biomarkers of Alzheimer’s disease such as amyloid, tau or phospho tau from positron emission tomography, cerebrospinal fluid or serum/plasma.